{{'Mon, 24 Jun 2024 13:30:00 -0400' | dateFormatUsFilter}}
Ozempic® (semaglutide) injection 1 mg demonstrated reduction in risk of kidney disease-related events in Phase 3 FLOW trial presented at the 84th Scientific Sessions of the American Diabetes Association
Read more
{{'Mon, 03 Jun 2024 10:00:00 -0400' | dateFormatUsFilter}}
Novo Nordisk launches national Wegovy® campaign, Power of Wegovy®
Read more
{{'Thu, 30 May 2024 10:00:00 -0400' | dateFormatUsFilter}}
Novo Nordisk escalates legal actions to safeguard patients from potentially harmful compounded “semaglutide” drugs
Read more
Here are our current job openings. If we don’t currently have an opening in your area of interest, we encourage you to create a job agent and candidate profile.